| 来源类型 | Working Paper
|
| 规范类型 | 报告
|
| DOI | 10.3386/w6366
|
| 来源ID | Working Paper 6366
|
| The Introduction of Pharmaceutical Product Patents in India: \"Heartless Exploitation of the Poor and Suffering\"? |
| Jean O. Lanjouw
|
| 发表日期 | 1998
|
| 出版年 | 1998
|
| 语种 | 英语
|
| 摘要 | The decision to require that countries grant product patents for pharmaceutical innovations as a condition of membership in the World Trade Organization was very contentious. Almost 50 developing countries were not granting patent monopolies for drugs during the period the Uruguay round of GATT was being debated and these countries fiercely resisted the inclusion of this requirement, claiming that vastly higher drug prices would be associated with such patents. On the other side, business interest in the West urged them to consider the benefits such protection might bring both in terms of focusing more research on tropical diseases and encouraging greater domestic and foreign investment in local research activities. This paper discusses the various theoretical implications for a developing country of introducing product patents for pharmaceuticals. Using India as an example, it then brings together information gathered from both published sources and personal interviews to examine the potential magnitude of these effects. While not arriving at a conclusive answer to the question posed in the title, there are some suggestions about the way events might unfold as the policy is implemented. |
| 主题 | Development and Growth
; Innovation and R&
; D
; Industrial Organization
; Industry Studies
|
| URL | https://www.nber.org/papers/w6366
|
| 来源智库 | National Bureau of Economic Research (United States)
|
| 引用统计 |
|
| 资源类型 | 智库出版物
|
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/563871
|
推荐引用方式
GB/T 7714 |
Jean O. Lanjouw. The Introduction of Pharmaceutical Product Patents in India: \"Heartless Exploitation of the Poor and Suffering\"?. 1998.
|
|
文件名：
|
w6366.pdf
|
|
格式：
|
Adobe PDF
|
此文件暂不支持浏览
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
